Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kent

Showing results (221-230 of 1,317) with videos related to

Pageof 132
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidineMonica I Jushchyshyn, Ute M Kent, Paul F Hollenberg
The American Journal of Cardiology|December 17, 2003
Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathyDaniel W Isenbarger, Steven M Kent, Patrick G O'Malley
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1994
Overview of antibody use in immunocytochemistryS Y Mao, L C Javois, U M Kent
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5Hsia-lien Lin, Ute M Kent, Paul F Hollenberg
Chest|April 12, 2005
Exercise testing in Wolff-Parkinson-White syndrome: case report with ECG and literature reviewMatthew R Jezior, Steven M Kent, J Edwin Atwood
Chemical Research in Toxicology|December 7, 2007
Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implicationsPaul F Hollenberg, Ute M Kent, Namandjé N Bumpus
Trials|May 24, 2008
Competing risk and heterogeneity of treatment effect in clinical trialsDavid M Kent, Alawi Alsheikh-Ali, Rodney A Hayward
Annals of Internal Medicine|December 2, 2024
A Framework for Considering the Value of Race and Ethnicity in Estimating Disease RiskMadison Coots, Soroush Saghafian, David M Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006
Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanismsNamandjé N Bumpus, Ute M Kent, Paul F Hollenberg
Pediatric Cardiology|June 21, 2014
Metastatic osteosarcoma to the interventricular septum: an unusual presentation in a childAnas S Taqatqa, Paul M Kent, Sawsan M Awad
Pageof 132

Showing results (221-230 of 1,317) with videos related to

Sort By:
Pageof 132
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidineMonica I Jushchyshyn, Ute M Kent, Paul F Hollenberg
The American Journal of Cardiology|December 17, 2003
Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathyDaniel W Isenbarger, Steven M Kent, Patrick G O'Malley
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1994
Overview of antibody use in immunocytochemistryS Y Mao, L C Javois, U M Kent
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5Hsia-lien Lin, Ute M Kent, Paul F Hollenberg
Chest|April 12, 2005
Exercise testing in Wolff-Parkinson-White syndrome: case report with ECG and literature reviewMatthew R Jezior, Steven M Kent, J Edwin Atwood
Chemical Research in Toxicology|December 7, 2007
Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implicationsPaul F Hollenberg, Ute M Kent, Namandjé N Bumpus
Trials|May 24, 2008
Competing risk and heterogeneity of treatment effect in clinical trialsDavid M Kent, Alawi Alsheikh-Ali, Rodney A Hayward
Annals of Internal Medicine|December 2, 2024
A Framework for Considering the Value of Race and Ethnicity in Estimating Disease RiskMadison Coots, Soroush Saghafian, David M Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006
Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanismsNamandjé N Bumpus, Ute M Kent, Paul F Hollenberg
Pediatric Cardiology|June 21, 2014
Metastatic osteosarcoma to the interventricular septum: an unusual presentation in a childAnas S Taqatqa, Paul M Kent, Sawsan M Awad
Pageof 132